• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Diabetes, Obesity, and Risk Prediction of Severe COVID-19.糖尿病、肥胖与重症 COVID-19 的风险预测
J Clin Endocrinol Metab. 2020 Oct 1;105(10). doi: 10.1210/clinem/dgaa442.
2
Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.预测因 SARS-CoV-2 导致的死亡率：一个将肥胖和糖尿病与墨西哥 COVID-19 结局相关联的机制评分。
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa346.
3
[Diabetes and hypertension as factors associated with Covid-19 lethality in Sonora, Mexico, 2020].[2020年，糖尿病和高血压作为墨西哥索诺拉州与新冠病毒致死率相关的因素]
Salud Publica Mex. 2020 Sep-Oct;62(5):456-457. doi: 10.21149/11546.
4
Is blood glucose or obesity responsible for the bad prognosis of COVID-19 in obesity - diabetes?血糖或肥胖是导致肥胖-糖尿病患者COVID-19预后不良的原因吗？
Diabetes Res Clin Pract. 2020 Sep;167:108342. doi: 10.1016/j.diabres.2020.108342. Epub 2020 Jul 27.
5
Response to Comment on Cai et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020;43:1392-1398.对关于蔡等人的评论的回应。中国深圳某指定医院的肥胖与新冠病毒病严重程度。《糖尿病护理》2020年；43:1392 - 1398。
Diabetes Care. 2020 Oct;43(10):e162. doi: 10.2337/dci20-0034.
6
Comment on Cai et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020;43:1392-1398.评论蔡等人的《中国深圳某指定医院的肥胖与2019冠状病毒病严重程度》。《糖尿病护理》2020年；43:1392 - 1398。
Diabetes Care. 2020 Oct;43(10):e160-e161. doi: 10.2337/dc20-1195.
7
COVID-19 and diabetes: a co-conspiracy?2019冠状病毒病与糖尿病：一种共同的“阴谋”？
Lancet Diabetes Endocrinol. 2020 Oct;8(10):801. doi: 10.1016/S2213-8587(20)30315-6.
8
Diabetes and COVID-19: Moving From News to Knowledge and a Glucose Hypothesis.糖尿病与新冠疫情：从新闻到知识及一个血糖假说
Diabetes Care. 2020 Oct;43(10):2336-2338. doi: 10.2337/dci20-0045. Epub 2020 Aug 4.
9
Pre-existing diabetes is worse for SARS-CoV-2 infection; an endothelial perspective.既往糖尿病对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染更为不利：内皮细胞视角
Nutr Metab Cardiovasc Dis. 2020 Sep 24;30(10):1855-1856. doi: 10.1016/j.numecd.2020.07.007. Epub 2020 Jul 9.
10
Prioritising action on diabetes during COVID-19.在2019冠状病毒病疫情期间优先采取糖尿病防治行动。
S Afr Med J. 2020 Jun 25;110(8):719-720.

引用本文的文献

1
The role of universal health coverage and global health security nexus and interplay on SARS-CoV-2 infection and case-fatality rates in Africa : a structural equation modeling approach.全民健康覆盖和全球卫生安全的关系及其对非洲 SARS-CoV-2 感染和病死率的结构方程模型分析
Global Health. 2023 Jul 6;19(1):46. doi: 10.1186/s12992-023-00949-2.
2
Machine learning models to predict the maximum severity of COVID-19 based on initial hospitalization record.基于初始住院记录的机器学习模型预测 COVID-19 最大严重程度。
Front Public Health. 2022 Nov 28;10:1007205. doi: 10.3389/fpubh.2022.1007205. eCollection 2022.
3
Increased circulating microparticles contribute to severe infection and adverse outcomes of COVID-19 in patients with diabetes.循环中增加的微颗粒导致糖尿病患者 COVID-19 的严重感染和不良结局。
Am J Physiol Heart Circ Physiol. 2022 Dec 1;323(6):H1176-H1193. doi: 10.1152/ajpheart.00409.2022. Epub 2022 Oct 21.
4
Risk factors for COVID-19-related mortality in hospitalized children and adolescents with diabetes mellitus: An observational retrospective cohort study.COVID-19 相关死亡风险因素在住院儿童和青少年糖尿病患者中的研究：一项观察性回顾性队列研究。
Pediatr Diabetes. 2022 Sep;23(6):763-772. doi: 10.1111/pedi.13335. Epub 2022 Mar 27.
5
Healthy Immunity on Preventive Medicine for Combating COVID-19.健康免疫与预防医学抗击新冠病毒。
Nutrients. 2022 Feb 27;14(5):1004. doi: 10.3390/nu14051004.
6
Obesity and COVID-19: what makes obese host so vulnerable?肥胖与新冠疫情：为何肥胖宿主如此脆弱？
Immun Ageing. 2021 Jan 4;18(1):1. doi: 10.1186/s12979-020-00212-x.
7
Pathways to Severe COVID-19 for People with Obesity.肥胖人群患严重 COVID-19 的途径。
Obesity (Silver Spring). 2021 Apr;29(4):645-653. doi: 10.1002/oby.23099.

本文引用的文献

1
Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course.代谢综合征与 COVID-19：内分泌-免疫-血管相互作用影响临床病程。
Endocrinology. 2020 Oct 1;161(10). doi: 10.1210/endocr/bqaa112.
2
Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020.2019 年冠状病毒病病例监测-美国，2020 年 1 月 22 日-5 月 30 日。
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):759-765. doi: 10.15585/mmwr.mm6924e2.
3
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.2020 年，由于潜在健康状况，全球、区域和国家估计有多少人面临 COVID-19 重症风险增加：一项建模研究。
Lancet Glob Health. 2020 Aug;8(8):e1003-e1017. doi: 10.1016/S2214-109X(20)30264-3. Epub 2020 Jun 15.
4
New-Onset Diabetes in Covid-19.新冠病毒感染引发的新发糖尿病
N Engl J Med. 2020 Aug 20;383(8):789-790. doi: 10.1056/NEJMc2018688. Epub 2020 Jun 12.
5
Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.预测因 SARS-CoV-2 导致的死亡率：一个将肥胖和糖尿病与墨西哥 COVID-19 结局相关联的机制评分。
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa346.
6
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal.COVID-19 诊断和预后预测模型：系统评价和批判性评估。
BMJ. 2020 Apr 7;369:m1328. doi: 10.1136/bmj.m1328.
7
Young-onset type 2 diabetes mellitus - implications for morbidity and mortality.青年发病的2型糖尿病——对发病率和死亡率的影响
Nat Rev Endocrinol. 2020 Jun;16(6):321-331. doi: 10.1038/s41574-020-0334-z. Epub 2020 Mar 20.

Diabetes, Obesity, and Risk Prediction of Severe COVID-19.

作者信息

Muniyappa Ranganath, Wilkins Kenneth J

机构信息

Clinical Endocrine Section, Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.

Office of the Director, Biostatistics Program/Office of Clinical Research Support, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.

出版信息

J Clin Endocrinol Metab. 2020 Oct 1;105(10). doi: 10.1210/clinem/dgaa442.

DOI:10.1210/clinem/dgaa442
PMID:32663259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7454695/
Abstract
摘要